SureTrader
Cannabis Stocks News
Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs > Inovio Pharmaceuticals, Inc. (INO)

http://www.nasdaq.com/symbol/ino/after-hours

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Banks Member Profile
 
Followed By 56
Posts 10,998
Boards Moderated 0
Alias Born 05/02/05
160x600 placeholder
Inovio dMAb™ Constructs Shrink Prostate Tumors and Protect Against Lethal Antibiotic-Resistant Bacterial Infection In Prec... "GlobeNewswire Inc." - 9/21/2017 8:00:00 AM
Inovio and Partners Initiate Phase 1/2a Clinical Trial To Further Advance Its Vaccine Against Deadly MERS Infection "GlobeNewswire Inc." - 9/18/2017 8:00:00 AM
Inovio’s Cancer Immunotherapy (INO-5150) Slowed PSA Rise and Significantly Increased PSA Doubling Times In Patients with R... "GlobeNewswire Inc." - 9/11/2017 8:00:00 AM
Inovio Pharmaceuticals to Participate in Upcoming Investment Conferences "GlobeNewswire Inc." - 8/23/2017 8:00:00 AM
Inovio Pharmaceuticals Reports 2017 Second Quarter Financial Results "GlobeNewswire Inc." - 8/8/2017 4:14:55 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 8/8/2017 3:50:29 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 8/1/2017 2:27:51 PM
Inovio Pharmaceuticals to Report Second Quarter 2017 Financial Results on August 8, 2017 "GlobeNewswire Inc." - 7/26/2017 8:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/20/2017 5:24:19 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 7/20/2017 4:37:59 PM
Inovio Announces Pricing of Public Offering of Common Stock "GlobeNewswire Inc." - 7/19/2017 10:10:00 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/18/2017 4:15:31 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 7/18/2017 4:05:53 PM
Inovio Announces Proposed Public Offering of Common Stock "GlobeNewswire Inc." - 7/18/2017 4:01:00 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/14/2017 9:11:08 AM
Inovio’s DNA-based Monoclonal Antibody Platform Achieves Further Proof-of-Principle Validation "GlobeNewswire Inc." - 7/6/2017 8:00:00 AM
Inovio Announces Leadership Appointments "GlobeNewswire Inc." - 6/28/2017 8:00:00 AM
Inovio Pharmaceuticals to Participate on Panel at 2017 BIO International Convention "GlobeNewswire Inc." - 6/19/2017 8:00:00 AM
Inovio Fully Enrolls 160 Subjects in Puerto Rico for Second Zika Vaccine Phase 1 Trial; Continues Leadership to Advance an Ef... "GlobeNewswire Inc." - 6/15/2017 8:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 6/12/2017 9:57:06 AM
Inovio Begins Phase 3 Clinical Trial of VGX-3100 for the Treatment of HPV-Related Cervical Pre-Cancer  "GlobeNewswire Inc." - 6/8/2017 6:00:00 AM
Inovio Zika Vaccine Prevents Persistence of Virus and Damage in Male Reproductive Tract in Pre-Clinical Study "GlobeNewswire Inc." - 6/7/2017 8:00:00 AM
Inovio Announces Clinical Trial Collaboration to Evaluate a Novel T-cell Immunotherapy in Combination with a PD-L1 Checkpoint... "GlobeNewswire Inc." - 6/1/2017 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 5/26/2017 4:25:23 PM
Inovio HIV Vaccine Elicits Nearly 100% Immune Response Rates in a Clinical Study "GlobeNewswire Inc." - 5/24/2017 8:00:00 AM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist